pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jul 29·1 min read
save

Morning Rounds flags overlooked pedestrian and cyclist deaths, upcoming Fauci Senate hearing, and research visa limits

Jul 29, 2026·read at STAT ↗Neutral

The latest Morning Rounds newsletter draws attention to the often‑ignored problem of deaths among pedestrians and cyclists, urging greater public health focus.

It also notes that Dr. Anthony Fauci is scheduled to testify before a Senate committee about the COVID‑19 pandemic, following a subpoena from Sen. Rand Paul and a pre‑emptive pardon by President Biden.

The edition mentions new visa time limits that could affect international research students, highlighting potential impacts on the scientific workforce.

Additionally, the newsletter promotes an upcoming Office Hours session with Isa Cueto and Lev Facher to discuss alcohol consumption as a public health crisis and related policy options.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “A neglected issue in pedestrian, biker deaths”

read at STAT ↗
1,064 words · retrieved Jul 29
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Gossamer Bio, Inc.
topics
Psychiatry & CNS2Infectious DiseaseOncologyPeptide TherapeuticType 2 Diabetes

related stories

  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • Jun 4Scientists uncover a new hiding spot for HIVSTAT
  • Dec 22Fierce Biotech Fundraising Tracker '26: Superluminal snags $60M; AusperBio adds $120MFierce Biotech
  • Jun 12Chile offers new data on food warning label efficacySTAT
  • Jun 11HHS responds coolly to paper on alcohol riskSTAT